|
Volumn 29, Issue 2, 2009, Pages 169-176
|
Therapy of rabies encephalitis.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMANTADINE;
AMINO ACID RECEPTOR BLOCKING AGENT;
ANTIVIRUS AGENT;
KETAMINE;
MIDAZOLAM;
NEUTRALIZING ANTIBODY;
PHENOBARBITAL;
RIBAVIRIN;
VIRUS ANTIBODY;
ADOLESCENT;
ANIMAL;
BAT;
BIOSYNTHESIS;
CLINICAL PROTOCOL;
DEEP SEDATION;
DRUG EFFECT;
EDITORIAL;
ELECTROENCEPHALOGRAPHY;
FEMALE;
HUMAN;
IMMUNOLOGY;
MULTIMODALITY CANCER THERAPY;
RABIES;
RABIES VIRUS;
VIROLOGY;
VIRUS ENCEPHALITIS;
ADOLESCENT;
AMANTADINE;
ANIMALS;
ANTIBODIES, NEUTRALIZING;
ANTIBODIES, VIRAL;
ANTIVIRAL AGENTS;
CHIROPTERA;
CLINICAL PROTOCOLS;
COMBINED MODALITY THERAPY;
DEEP SEDATION;
ELECTROENCEPHALOGRAPHY;
ENCEPHALITIS, VIRAL;
EXCITATORY AMINO ACID ANTAGONISTS;
FEMALE;
HUMANS;
KETAMINE;
MIDAZOLAM;
PHENOBARBITAL;
RABIES;
RABIES VIRUS;
RIBAVIRIN;
|
EID: 77951239220
PISSN: 01204157
EISSN: None
Source Type: Journal
DOI: 10.7705/biomedica.v29i2.18 Document Type: Editorial |
Times cited : (13)
|
References (0)
|